Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Shimozawa

Showing results (41-50 of 167) with videos related to

Pageof 17
Sort By:
The British Journal of Dermatology|April 12, 2001
An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazemY Ichiki, T Akiyama, N Shimozawa, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 29, 1988
Molecular analysis of peroxisomal beta-oxidation enzymes in infants with Zellweger syndrome and Zellweger-like syndrome: further heterogeneity of the peroxisomal disorderY Suzuki, N Shimozawa, T Orii, et al.
Electroencephalography and Clinical Neurophysiology|March 1, 1988
Origin and clinical significance of subcortical components in short-latency somatosensory evoked potentials in childrenY Tomita, T Tanaka, N Kamimura, et al.
Clinical Chemistry|November 20, 1997
Very long chain fatty acid analysis of dried blood spots on filter paper to screen for adrenoleukodystrophyK Inoue, Y Suzuki, S Yajima, et al.
American Journal of Human Genetics|December 5, 1998
Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group DM Honsho, S Tamura, N Shimozawa, et al.
Biochemical Pharmacology|February 1, 1991
Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on fatty acid oxidation in fibroblasts from patients with peroxisomal diseasesY Suzuki, N Shimozawa, S Yajima, et al.
Clinical Genetics|February 9, 2000
Prenatal diagnosis of peroxisome biogenesis disorders by means of immunofluorescence staining of cultured chorionic villous cellsZ Zhang, Y Suzuki, N Shimozawa, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|January 5, 2000
Glucose metabolism evaluated by positron emission tomography in Lafora diseaseZ Kato, K Yasuda, K Ishii, et al.
Brain & Development|July 1, 1994
Short latency somatosensory evoked potentials and 99mTc-HMPAO SPECT in a case of flunarizine-effective alternating hemiplegia in infancyA Imamura, Y Komori, O Fukutomi, et al.
American Journal of Human Genetics|April 1, 1993
Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defectN Shimozawa, Y Suzuki, T Orii, et al.
Pageof 17

Showing results (41-50 of 167) with videos related to

Sort By:
Pageof 17
The British Journal of Dermatology|April 12, 2001
An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazemY Ichiki, T Akiyama, N Shimozawa, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 29, 1988
Molecular analysis of peroxisomal beta-oxidation enzymes in infants with Zellweger syndrome and Zellweger-like syndrome: further heterogeneity of the peroxisomal disorderY Suzuki, N Shimozawa, T Orii, et al.
Electroencephalography and Clinical Neurophysiology|March 1, 1988
Origin and clinical significance of subcortical components in short-latency somatosensory evoked potentials in childrenY Tomita, T Tanaka, N Kamimura, et al.
Clinical Chemistry|November 20, 1997
Very long chain fatty acid analysis of dried blood spots on filter paper to screen for adrenoleukodystrophyK Inoue, Y Suzuki, S Yajima, et al.
American Journal of Human Genetics|December 5, 1998
Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group DM Honsho, S Tamura, N Shimozawa, et al.
Biochemical Pharmacology|February 1, 1991
Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on fatty acid oxidation in fibroblasts from patients with peroxisomal diseasesY Suzuki, N Shimozawa, S Yajima, et al.
Clinical Genetics|February 9, 2000
Prenatal diagnosis of peroxisome biogenesis disorders by means of immunofluorescence staining of cultured chorionic villous cellsZ Zhang, Y Suzuki, N Shimozawa, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|January 5, 2000
Glucose metabolism evaluated by positron emission tomography in Lafora diseaseZ Kato, K Yasuda, K Ishii, et al.
Brain & Development|July 1, 1994
Short latency somatosensory evoked potentials and 99mTc-HMPAO SPECT in a case of flunarizine-effective alternating hemiplegia in infancyA Imamura, Y Komori, O Fukutomi, et al.
American Journal of Human Genetics|April 1, 1993
Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defectN Shimozawa, Y Suzuki, T Orii, et al.
Pageof 17